Skip to main content

Table 1 The clinical features and genes expressed in the CIN and SCC groups

From: Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia

  CIN SCC Z/X2 P
age 41.71 ± 9.31 49.87 ± 10.03 −3.575 0.000
gravidity 3.46 ± 1.84 4.00 ± 1.44 −1.720 0.085
parity 1.67 ± 1.34 2.30 ± 1.34 −2.377 0.017
HPV infection
 positive 47 28 / 1.000
 negative 5 2   
menopause    13.610 0.000
 yes 9 17   
 no 43 13   
TCT     0.109
 CINII-(Normal/ASCUS) 16 4 /  
 CINII+(LSIL/HSIL/SCC) 36 26   
 CTNNB1 0.88 ± 0.24 4.23 ± 2.47 −1.637 0.102
TGFBR2 665.56 ± 357.49 15,156.14 ± 9065.91 −3.023 0.003
FOXO1 0.50 ± 0.30 0.10 ± 0.05 −3.110 0.002
PRKCI 0.56 ± 0.11 5.49 ± 2.66 −4.130 0.000
CSKN1A1 135.69 ± 81.39 4062.52 ± 1658.02 −3.783 0.000
TP73 75.39 ± 21.31 408.60 ± 145.24 −1.714 0.087
MUC2 1.89 ± 1.26 1.35 ± 0.70 −1.271 0.204
PIK3CA 7.28 ± 1.98 8.60 ± 3.22 −0.053 0.958
CCND2 1.40 ± 0.72 0.53 ± 0.25 −1.078 0.281
CTPB2 16.59 ± 6.14 599.16 ± 375.43 −2.089 0.037